DOP034 Serum adalimumab concentration 3 months after surgery is correlated with endoscopic recurrence in Crohn's disease patients treated with adalimumab for prevention of postoperative recurrence | Zendy

AI Assistant Blog Pricing

DOP034 Serum adalimumab concentration 3 months after surgery is correlated with endoscopic recurrence in Crohn's disease patients treated with adalimumab for prevention of postoperative recurrence

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.